SWOG clinical trial number
SWOG-7435
Piperazineclione (Crystalline Antibiotic) for Patients with Malignant Lymphoma or Multiple Myeloma
Closed
Abbreviated Title
Piperazineclione (Crystalline Antibiotic) for Patients with Malignant Lymphoma or Multiple Myeloma
Activated
12/27/1974
Closed
10/21/1976
Publication Information Expand/Collapse
1977
Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study
1976
Phase II trial of piperazinedione (crystalline antibiotic) in lymphoma and multiple myeloma.
Phase II trial of piperazinedione (crystalline antibiotic) in lymphoma and multiple myeloma.